WHO ICTRP trial

A randomised trial of radiotherapy alone versus three cycles of…

ISRCTN55593137 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN55593137
Public title A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphoma
Scientific title A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphoma
Primary sponsor Cancer Research UK (CRUK) (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries United Kingdom
Conditions Non-Hodgkin's lymphoma Cancer Non-Hodgkin's lymphoma
Interventions Patients are randomised to one of three treatment regimens: 1. Regimen A: Radiotherapy 40 Gy in twenty to twenty-five fractions. 2. Regimen B: Chemotherapy with cylophosphamide, doxorubicin, vincristine and prednisolone (CHOP) repeated…
Registration date Jan 7, 2001
Target size 0
Secondary IDs LY05
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations